{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:41:09Z","timestamp":1790988069711,"version":"4.1.0"},"reference-count":121,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Pediatric dilated cardiomyopathy (DCM) is a rare, yet life-threatening cardiovascular condition characterized by systolic dysfunction with biventricular dilatation and reduced myocardial contractility. Therapeutic options are limited with nearly 40% of children undergoing heart transplant or death within 2 years of diagnosis. Pediatric patients are currently diagnosed based on correlating the clinical picture with echocardiographic findings. Patient age, etiology of disease, and parameters of cardiac function significantly impact prognosis. Treatments for pediatric DCM aim to ameliorate symptoms, reduce progression of disease, and prevent life-threatening arrhythmias. Many therapeutic agents with known efficacy in adults lack the same evidence in children. Unlike adult DCM, the pathogenesis of pediatric DCM is not well understood as approximately two thirds of cases are classified as idiopathic disease. Children experience unique gene expression changes and molecular pathway activation in response to DCM. Studies have pointed to a significant genetic component in pediatric DCM, with variants in genes related to sarcomere and cytoskeleton structure implicated. In this regard, pediatric DCM can be considered pediatric manifestations of inherited cardiomyopathy syndromes. Yet exciting recent studies in infantile DCM suggest that this subset has a distinct etiology involving defective postnatal cardiac maturation, such as the failure of programmed centrosome breakdown in cardiomyocytes. Improved knowledge of pathogenesis is central to developing child-specific treatment approaches. This review aims to discuss the established biological pathogenesis of pediatric DCM, current clinical guidelines, and promising therapeutic avenues, highlighting differences from adult disease. The overarching goal is to unravel the complexities surrounding this condition to facilitate the advancement of novel therapeutic interventions and improve prognosis and overall quality of life for pediatric patients affected by DCM.<\/jats:p>","DOI":"10.3389\/fped.2024.1404942","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:37:55Z","timestamp":1718757475000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Pediatric dilated cardiomyopathy: a review of current clinical approaches and pathogenesis"],"prefix":"10.3389","volume":"12","author":[{"given":"Ian","family":"Malinow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.mpdhp.2019.05.003","article-title":"Aspects of paediatric cardiovascular pathology","volume":"25","author":"Ashworth","year":"2019","journal-title":"Diagn Histopathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American heart association","volume":"140","author":"Lipshultz","year":"2019","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The incidence of pediatric cardiomyopathy in two regions of the United States","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.healun.2003.11.397","article-title":"Heart transplant and left ventricular assist device costs","volume":"24","author":"DiGiorgi","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"B6","first-page":"S107","article-title":"Economic impact of heart failure in the United States: time for a different approach","volume":"13","author":"O\u2019Connell","year":"1994","journal-title":"J Heart Lung Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.hjc.2023.02.007","article-title":"Cardiomyopathies in children: an overview","volume":"72","author":"Tsatsopoulou","year":"2023","journal-title":"Hellenic J Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1542\/peds.2006-0163","article-title":"Factors associated with establishing a causal diagnosis for children with cardiomyopathy","volume":"118","author":"Cox","year":"2006","journal-title":"Pediatrics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2217\/fca.13.66","article-title":"Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies","volume":"9","author":"Lipshultz","year":"2013","journal-title":"Future Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ppedcard.2014.10.003","article-title":"Genetic causes of dilated cardiomyopathy","volume":"37","author":"Mestroni","year":"2014","journal-title":"Prog Pediatr Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.hfc.2010.05.002","article-title":"The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years","volume":"6","author":"Wilkinson","year":"2010","journal-title":"Heart Fail Clin"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1161\/CIRCULATIONAHA.106.635128","article-title":"Clinical features and outcomes of childhood dilated cardiomyopathy","volume":"114","author":"Daubeney","year":"2006","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.cir.93.5.841","article-title":"Report of the 1995 world health organization\/international society and federation of cardiology task force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC","volume":"14","author":"McMurray JJ","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"B16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated cardiomyopathy","volume":"121","author":"McNally","year":"2017","journal-title":"Circ Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1532-429X-10-50","article-title":"Cardiac involvement in patients with becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach","volume":"10","author":"Yilmaz","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.jacc.2006.10.078","article-title":"Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy","volume":"49","author":"Silva","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1532-429X-15-107","article-title":"Prevalence and distribution of late gadolinium enhancement in a large population of patients with duchenne muscular dystrophy: effect of age and left ventricular systolic function","volume":"15","author":"Hor","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.3390\/jcm12144866","article-title":"The role of multimodality imaging in pediatric cardiomyopathies","volume":"12","author":"Moscatelli","year":"2023","journal-title":"J Clin Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10741-022-10235-9","article-title":"Clinical application of CMR in cardiomyopathies: evolving concepts and techniques","volume":"28","author":"Merlo","year":"2022","journal-title":"Heart Fail Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy\u2014a heart failure society of America practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"key":"B23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199201093260201","article-title":"The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy","volume":"326","author":"Michels V","year":"1992","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the heart rhythm society (HRS) and the European heart rhythm association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"B25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1096\/fasebj.10.7.8635691","article-title":"G protein-coupled receptors and signaling pathways regulating growth responses 1","volume":"10","author":"Post","year":"1996","journal-title":"FASEB J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/36362","article-title":"Switching of the coupling of the \u03b22-adrenergic receptor to different G proteins by protein kinase A","volume":"390","author":"Daaka","year":"1997","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/eurheartj\/ehs229","article-title":"Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy","volume":"35","author":"Miyamoto","year":"2014","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/B978-0-12-801734-0.00073-4","article-title":"Reversibility of renal fibrosis","volume-title":"Kidney Transplantation, Bioengineering, and Regeneration: Kidney Transplantation in the Regenerative Medicine Era","author":"Chadjichristos","year":"2017"},{"key":"B29","doi-asserted-by":"publisher","first-page":"110203","DOI":"10.1016\/j.cellsig.2021.110203","article-title":"Function and regulation of phosphatase 1 in healthy and diseased heart","volume":"90","author":"Klapproth","year":"2022","journal-title":"Cell Signal"},{"key":"B30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3109\/07853890008998837","article-title":"Phospholamban and cardiac contractility","volume":"32","author":"Frank","year":"2000","journal-title":"Ann Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94249","article-title":"Pediatric dilated cardiomyopathy hearts display a unique gene expression profile","volume":"2","author":"Tatman","year":"2017","journal-title":"JCI Insight"},{"key":"B32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cardfail.2016.11.006","article-title":"Fibrosis and fibrotic gene expression in pediatric and adult patients with idiopathic dilated cardiomyopathy","volume":"23","author":"Woulfe","year":"2017","journal-title":"J Card Fail"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94382","article-title":"Pediatric and adult dilated cardiomyopathy represent distinct pathological entities","volume":"2","author":"Patel","year":"2017","journal-title":"JCI Insight"},{"key":"B34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1442-200X.2010.03250.x","article-title":"Histopathological aspects of cardiac biopsy in pediatric patients with dilated cardiomyopathy","volume":"53","author":"Nishikawa","year":"2011","journal-title":"Pediatr Int"},{"key":"B35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/CIRCHEARTFAILURE.108.839001","article-title":"Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy","volume":"2","author":"Singh","year":"2009","journal-title":"Circ Heart Fail"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e31111","DOI":"10.7759\/cureus.31111","article-title":"Dilated cardiomyopathy in children: early detection and treatment","volume":"14","author":"Mallavarapu","year":"2022","journal-title":"Cureus"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e19658","DOI":"10.7759\/cureus.19658","article-title":"Pediatric chemotherapy drugs associated with cardiotoxicity","volume":"13","author":"Hitawala","year":"2021","journal-title":"Cureus"},{"key":"B38","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/CIRCRESAHA.116.309386","article-title":"Pediatric cardiomyopathies","volume":"121","author":"Lee","year":"2017","journal-title":"Circ Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ppedcard.2010.11.008","article-title":"Rare variant mutations identified in pediatric patients with dilated cardiomyopathy","volume":"31","author":"Rampersaud","year":"2011","journal-title":"Prog Pediatr Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.104.507699","article-title":"\u03b1-myosin heavy chain","volume":"112","author":"Carniel","year":"2005","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0006-291X(02)02374-4","article-title":"Novel mutations in sarcomeric protein genes in dilated cardiomyopathy","volume":"298","author":"Daehmlow","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"105071","DOI":"10.1016\/j.dib.2019.105071","article-title":"Data on the role of cardiac \u03b1-actin (ACTC1) gene mutations on SRF-signaling","volume":"28","author":"Rangrez","year":"2020","journal-title":"Data Brief"},{"key":"B43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10741-005-5252-6","article-title":"Sarcomeric protein mutations in dilated cardiomyopathy","volume":"10","author":"Chang","year":"2005","journal-title":"Heart Fail Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCGENETICS.108.846733","article-title":"Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy","volume":"2","author":"Hershberger","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01612","article-title":"Familial dilated cardiomyopathy associated with a novel combination of compound heterozygous TNNC1 variants","volume":"10","author":"Landim-Vieira","year":"2020","journal-title":"Front Physiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"13471","DOI":"10.1074\/jbc.M509561200","article-title":"Increased Ca2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I","volume":"281","author":"Kobayashi","year":"2006","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1007\/s00018-008-8080-8","article-title":"\u03b1-actinin structure and regulation","volume":"65","author":"Sj\u00f6blom","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/humu.24004","article-title":"A mutation update for the FLNC gene in myopathies and cardiomyopathies","volume":"41","author":"Verdonschot","year":"2020","journal-title":"Hum Mutat"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.006935","article-title":"Nexilin is necessary for maintaining the transverse-axial tubular system in adult cardiomyocytes","volume":"13","author":"Spinozzi","year":"2020","journal-title":"Circ Heart Fail"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1002\/ajmg.a.62231","article-title":"Childhood onset nexilin dilated cardiomyopathy: a heterozygous and a homozygous case","volume":"185","author":"Bruyndonckx","year":"2021","journal-title":"Am J Med Genet A"},{"key":"B51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cardfail.2012.01.013","article-title":"Genetic testing for dilated cardiomyopathy in clinical practice","volume":"18","author":"Lakdawala","year":"2012","journal-title":"J Card Fail"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","article-title":"Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy","volume":"343","author":"Kamisago","year":"2000","journal-title":"N Engl J Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/humu.20250","article-title":"Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy","volume":"26","author":"Taylor","year":"2005","journal-title":"Hum Mutat"},{"key":"B55","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0735-1097(02)02954-6","article-title":"Natural history of dilated cardiomyopathy due to lamin A\/C gene mutations","volume":"41","author":"Taylor","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/jcs.114.1.9","article-title":"Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes?","volume":"114","author":"Hutchison","year":"2001","journal-title":"J Cell Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0962-8924(99)01708-0","article-title":"The nuclear envelope, muscular dystrophy and gene expression","volume":"10","author":"Wilson","year":"2000","journal-title":"Trends Cell Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1161\/01.CIR.0000144458.58660.BB","article-title":"SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia","volume":"110","author":"McNair","year":"2004","journal-title":"Circulation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science (1979)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","article-title":"SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism","volume":"57","author":"McNair","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.106.646778","article-title":"Prevalence of desmin mutations in dilated cardiomyopathy","volume":"115","author":"Taylor","year":"2007","journal-title":"Circulation"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.jacc.2003.10.021","article-title":"Mutations in cypher\/ZASPin patients with dilated cardiomyopathy and left ventricular non-compaction","volume":"42","author":"Vatta","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1161\/01.CIR.87.6.1854","article-title":"X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus","volume":"87","author":"Towbin","year":"1993","journal-title":"Circulation"},{"key":"B64","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/hc0402.102930","article-title":"Metavinculin mutations Alter actin interaction in dilated cardiomyopathy","volume":"105","author":"Olson","year":"2002","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ana.20973","article-title":"Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness","volume":"60","author":"Murakami","year":"2006","journal-title":"Ann Neurol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.107.689984","article-title":"Laminin-\u03b14 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells","volume":"116","author":"Kn\u00f6ll","year":"2007","journal-title":"Circulation"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1093\/hmg\/9.18.2761","article-title":"Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma","volume":"9","author":"Norgett","year":"2000","journal-title":"Hum Mol Genet"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/CIRCULATIONAHA.122.060985","article-title":"Impaired reorganization of centrosome structure underlies human infantile dilated cardiomyopathy","volume":"147","author":"Chun","year":"2023","journal-title":"Circulation"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/humu.21603","article-title":"Dilated cardiomyopathy-associated BAG3 mutations impair Z-disc assembly and enhance sensitivity to apoptosis in cardiomyocytes","volume":"32","author":"Arimura","year":"2011","journal-title":"Hum Mutat"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/jcp.24615","article-title":"Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathy","volume":"229","author":"Feldman","year":"2014","journal-title":"J Cell Physiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.3390\/jcm10184101","article-title":"RBM20-related cardiomyopathy: current understanding and future options","volume":"10","author":"Koelemen","year":"2021","journal-title":"J Clin Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s000590050003","article-title":"The \u201cfinal common pathway\u201d hypothesis and inherited cardiovascular disease","volume":"25","author":"Bowles","year":"2000","journal-title":"Herz"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.121.057763","article-title":"Defining the fetal gene program at single-cell resolution in pediatric dilated cardiomyopathy","volume":"146","author":"Mehdiabadi","year":"2022","journal-title":"Circulation"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022854\/FORMAT\/EPUB","article-title":"Genotype and cardiac outcomes in pediatric dilated cardiomyopathy","volume":"11","author":"Khan","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.120.002981","article-title":"Genetic evaluation of A nation-wide Dutch pediatric DCM cohort: the use of genetic testing in risk stratification","author":"van der Meulen","year":"2022","journal-title":"Circ Genom Precis Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1113\/JP276754","article-title":"Regulation of cardiomyocyte maturation during critical perinatal window","volume":"598","author":"Kannan","year":"2020","journal-title":"J Physiol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.10.032","article-title":"Transcriptional landscape of cardiomyocyte maturation","volume":"13","author":"Uosaki","year":"2015","journal-title":"Cell Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1009305","DOI":"10.1371\/JOURNAL.PCBI.1009305","article-title":"Transcriptomic entropy benchmarks stem cell-derived cardiomyocyte maturation against endogenous tissue at single cell level","volume":"17","author":"Kannan","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-06347-2","article-title":"Hierarchical and stage-specific regulation of murine cardiomyocyte maturation by serum response factor","volume":"9","author":"Guo","year":"2018","journal-title":"Nat Commun"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms4416","article-title":"Mutations in alstr\u00f6m protein impair terminal differentiation of cardiomyocytes","volume":"5","author":"Shenje","year":"2014","journal-title":"Nat Commun"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jacc.2013.11.059","article-title":"Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy","volume":"63","author":"Everitt","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ppedcard.2007.05.009","article-title":"Outcome predictors for pediatric dilated cardiomyopathy: a systematic review","volume":"23","author":"Alvarez","year":"2007","journal-title":"Prog Pediatr Cardiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1017\/S1047951107000170","article-title":"Outcome factors of idiopathic dilated cardiomyopathy in children\u2014a long-term follow-up review","volume":"17","author":"Azevedo","year":"2007","journal-title":"Cardiol Young"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/CIRCULATIONAHA.110.011999","article-title":"Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy","volume":"126","author":"Pietra","year":"2012","journal-title":"Circulation"},{"key":"B85","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2011.10.878","article-title":"Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy","volume":"59","author":"Pahl","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.healun.2011.01.718","article-title":"The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy","volume":"30","author":"Larsen","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"B87","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2004.04.035","article-title":"Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation","volume":"44","author":"Tsirka","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.708732","article-title":"Overview of cardiomyopathies in childhood","volume":"9","author":"Rath","year":"2021","journal-title":"Front Pediatr"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.jacc.2017.09.1089","article-title":"Survival without cardiac transplantation among children with dilated cardiomyopathy","volume":"70","author":"Singh","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: executive summary","volume":"33","author":"Kirk","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"B91","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.amjcard.2009.03.033","article-title":"Treating children with idiopathic dilated cardiomyopathy (from the pediatric cardiomyopathy registry)","volume":"104","author":"Harmon","year":"2009","journal-title":"Am J Cardiol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00246-020-02485-x","article-title":"Establishing baseline metrics of heart failure medication use in children: a collaborative effort from the ACTION network","volume":"42","author":"Stidham","year":"2021","journal-title":"Pediatr Cardiol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIR.0000000000001151","article-title":"Treatment strategies for cardiomyopathy in children: a scientific statement from the American heart association","volume":"148","author":"Bogle","year":"2023","journal-title":"Circulation"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jacc.2017.07.725","article-title":"Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure","volume":"70","author":"Bonnet","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ahj.2017.07.006","article-title":"Design for the sacubitril\/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study)","volume":"193","author":"Shaddy","year":"2017","journal-title":"Am Heart J"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jacc.2009.11.059","article-title":"The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy","volume":"55","author":"Kantor","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","article-title":"Carvedilol for children and adolescents with heart failure","volume":"298","author":"Shaddy","year":"2007","journal-title":"JAMA"},{"key":"B98","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0002-9149(02)03374-X","article-title":"Improving clinical outcomes with drug treatment in heart failure: what have trials taught?","volume":"91","author":"Konstam","year":"2003","journal-title":"Am J Cardiol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.845406","article-title":"Real-world use of carvedilol in children with dilated cardiomyopathy: long-term effect on survival and ventricular function","volume":"10","author":"Adorisio","year":"2022","journal-title":"Front Pediatr"},{"key":"B100","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/0974-2069.52816","article-title":"Is there a role for carvedilol in the management of pediatric heart failure? A meta analysis and e-mail survey of expert opinion","volume":"2","author":"Vaidyanathan","year":"2009","journal-title":"Ann Pediatr Cardiol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00246-010-9700-2","article-title":"Echocardiographic evaluation of children with systemic ventricular dysfunction treated with carvedilol","volume":"31","author":"Petko","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure A randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"B103","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","article-title":"Heart failure etiology and response tomilrinone in decompensated heart failure","volume":"41","author":"Felker","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.healun.2007.02.004","article-title":"Home inotropic therapy in children","volume":"26","author":"Berg A","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"B105","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cardfail.2005.11.001","article-title":"Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure","volume":"12","author":"Price","year":"2006","journal-title":"J Card Fail"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1161\/01.CIR.0000072766.67150.51","article-title":"Interferon-\u03b2 treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction","volume":"107","author":"K\u00fchl","year":"2003","journal-title":"Circulation"},{"key":"B107","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00392-016-0986-9","article-title":"Betaferon in chronic viral cardiomyopathy (BICC) trial: effects of interferon-\u03b2 treatment in patients with chronic viral cardiomyopathy","volume":"105","author":"Schultheiss","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001001","article-title":"Diagnosis and management of myocarditis in children","volume":"144","author":"Law","year":"2021","journal-title":"Circulation"},{"key":"B109","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1161\/CIRCULATIONAHA.113.001372","article-title":"Diagnosis and treatment of myocarditis in children in the current era","volume":"129","author":"Canter","year":"2014","journal-title":"Circulation"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009068.pub3","article-title":"Interventions for preventing and treating cardiac complications in duchenne and becker muscular dystrophy and X-linked dilated cardiomyopathy","volume":"10","author":"Bourke","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B111","doi-asserted-by":"publisher","first-page":"101460","DOI":"10.1016\/j.ppedcard.2021.101460","article-title":"Genetic correction strategies for duchenne muscular dystrophy and their impact on the heart","volume":"63","author":"Johnston","year":"2021","journal-title":"Prog Pediatr Cardiol"},{"key":"B112","first-page":"385","article-title":"Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management","volume":"40","author":"Meyers","year":"2013","journal-title":"Tex Heart Inst J"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004426.pub3","article-title":"Treatment for mitochondrial disorders","author":"Pfeffer","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B114","doi-asserted-by":"publisher","first-page":"785","DOI":"10.4070\/kcj.2013.43.12.785","article-title":"Primary carnitine deficiency and cardiomyopathy","volume":"43","author":"Fu","year":"2013","journal-title":"Korean Circ J"},{"key":"B115","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41436-020-01006-8","article-title":"A phase 2\/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism","volume":"23","author":"Thompson W","year":"2021","journal-title":"Genet Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s10741-021-10177-8","article-title":"Elamipretide for barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid","volume":"27","author":"Sabbah","year":"2022","journal-title":"Heart Fail Rev"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1200\/JCO.22.02423","article-title":"Dexrazoxane and long-term heart function in survivors of childhood cancer","volume":"41","author":"Chow","year":"2023","journal-title":"J Clin Oncol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829e8776","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"B119","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"key":"B120","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.amjcard.2022.08.001","article-title":"Long-term efficacy and safety of ARRY-371797 (PF-07265803) in patients with lamin A\/C\u2013related dilated cardiomyopathy","volume":"183","author":"Judge","year":"2022","journal-title":"Am J Cardiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ahj.2010.07.012","article-title":"Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure","volume":"160","author":"Rusconi","year":"2010","journal-title":"Am Heart J"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1404942\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:38:01Z","timestamp":1718757481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1404942\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":121,"alternative-id":["10.3389\/fped.2024.1404942"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1404942","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"article-number":"1404942"}}